Kaylee E Caniff

Eugene Applebaum College of Pharmacy and Health Sciences — United States

Immunology and Microbiology · Life Sciences

7h-index158citations28works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Use and Resistance(11), Antibiotic Resistance in Bacteria(9), Antibiotics Pharmacokinetics and Efficacy(9), Bacterial Identification and Susceptibility Testing(6), Antimicrobial Resistance in Staphylococcus(4)

Publications28 total

Optimizing discharge antibiotic prescribing: A multicenter evaluation of pharmacist-led interventions in community hospitals
American Journal of Health-System Pharmacy·2026
Clinical Evaluation of Omadacycline for Pulmonary Mycobacterium abscessus Complex Infections: A Subgroup Analysis with a Focus on Macrolide Resistance
CHEST Pulmonary·2026Open Access
P-874. Examining Outpatient Antibiotic Prescribing Trends and Guideline Concordance Across Urban and Rural Healthcare Facilities
Open Forum Infectious Diseases·2026Open Access
P-1210. Real-World Efficacy and Safety of Meropenem-Vaborbactam in Patients with Moderate to Severe Renal Impairment
Open Forum Infectious Diseases·2026Open Access
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections
Infectious Diseases and Therapy·2025Open Access
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections
Infectious Diseases and Therapy·2025· 3 citedOpen Access
Evaluating antimicrobial stewardship strategies in candidemia: a novel desirability of outcome ranking (DOOR) analysis comparing blood culture versus T2Candida diagnostic approaches
Journal of Clinical Microbiology·2025· 1 citedOpen Access
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study
Open Forum Infectious Diseases·2025· 10 citedOpen Access
P-1500. Evaluation of Imipenem-cilastatin-relebactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
Open Forum Infectious Diseases·2025· 1 citedOpen Access
646. Clinical and microbiological outcomes of omadacycline for pulmonary <i>Mycobacterium abscessus complex</i>
Open Forum Infectious Diseases·2025Open Access
P-289. Short-Duration vs. Long-Duration of Therapy for Hospital-Acquired or Ventilator-Associated Pneumonia due to Multi-Drug Resistant <i>Pseudomonas aeruginosa</i>
Open Forum Infectious Diseases·2025· 1 citedOpen Access
P-1801. Optimizing Antimicrobial Therapy in Gram-Negative Bloodstream Infections: Insights from a Pharmacist-Driven Intervention Leveraging Molecular Rapid Diagnostic Testing
Open Forum Infectious Diseases·2025Open Access
P-1499. Patient Characteristics and Clinical Outcomes Associated with Meropenem/Vaborbactam Treatment in Carbapenem-Resistant <i>Enterobacterales</i> Pneumonia
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Collaboration to harmonize antimicrobial registry measures (CHARM) database analysis of antibiotic prescribing in urgent and non-urgent care: a retrospective study on demographic factors
Antimicrobial Stewardship & Healthcare Epidemiology·2025Open Access
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2024· 23 citedOpen Access
Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus
Infectious Diseases and Therapy·2024· 1 citedOpen Access
810. Predictors of 30-Day Mortality Among Critically Ill Patients with Candidemia Identified by T2Candida Panel
Open Forum Infectious Diseases·2023Open Access
1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
Open Forum Infectious Diseases·2023· 1 citedOpen Access
2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success
Open Forum Infectious Diseases·2023Open Access
Steno‐sphere: Navigating the enigmatic world of emerging <scp>multidrug‐resistant</scp><i>Stenotrophomonas maltophilia</i>
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2023· 11 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Michael J. Rybak(13), Ashlan J. Kunz Coyne(9), Mohammed Al Musawa(8), Michael P. Veve(8), Kristen Lucas(7), Charles S. Judd(6), Mark Biagi(5), Athena L V Hobbs(5), Justin Andrade(5), Callan Bleick(4), Shelbye Herbin(4), Nicholas Rebold(4), Sara Alosaimy(4), Taryn A Eubank(4), Kevin W. Garey(4), Tamara Krekel(4), Wesley D. Kufel(4), Elisabeth Chandler(4), Taylor Morrisette(4), Marco R. Scipione(4)